Browsing by Author Gratwohl, A.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 4 of 4
Issue DateTitleAuthor(s)Citation
2015Allogeneic haematopoietic stem cell transplantation for mitochondrial neurogastrointestinal encephalomyopathySue, Carolyn; Accarino, Anna; Bakker, Jaap A.; Barba, Pere; Beguin, Yves; Boelens, Jaap; Casali, C; Chinnery, Patrick F; Collin, Matthew; de Coo, Irenaeus F. M.; Dotti, Maria T.; Elhasid, R; Fay, Keith; Ferra, Chrristelle; Filosto, Massimiliano; Gratwohl, A.; Halter, Jörg; Hammans, Simon; Hirano, M; Illa, Isabel; M Sue, C; Mandel, Hanna; Marotta, Giuseppe; Marti, Ramon; Nachbaur, David; Orchard, Kim; Pinto Simoes, Belinda; Pintos, Guillem; Rovelli, Attilio; Savage, David; Schupbach, W. Michael M.; Sobreira, Claudia; Valcarel, David; Zoller, Heinz; Northern Clinical School: MedicineAllogeneic haematopoietic stem cell transplantation for mitochondrial neurogastrointestinal encephalomyopathy, Brain, vol.138, 10, 2015,pp 2847-2858
2003Differences between graft product and donor side effects following bone marrow or stem cell donationBradstock, Kenneth; Apperley, J.; Bacigalupo, A.; Beksac, M.; Buzyn, A.; Favre, G.; Gluckman, E.; Gratwohl, A.; Matcham, J.; Nagler, A.; Russell, N.; Ruutu, T.; Schmitz, N.; Szer, J.; Western Clinical School: Westmead Millennium InstituteDifferences between graft product and donor side effects following bone marrow or stem cell donation, Bone Marrow Transplantation, vol.32,(9),2003,pp 873-880
2011Donor Characteristics Affecting Graft Failure, Graft-versus-Host Disease, and Survival after Unrelated Donor Transplantation with Reduced-Intensity Conditioning for Hematologic MalignanciesGibson, John; Champlin, Richard; Eapen, Mary; Gee, Adrian; Gratwohl, A.; Isola, Luis; Kan, Fangyu; Laughlin, Mary; Lazarus, Hillard M.; Loren, Alison; Marks, DI; Passweg, Jakob; Rocha, Vanderson; Zhang, Mei-Jie; Central Clinical School: MedicineDonor Characteristics Affecting Graft Failure, Graft-versus-Host Disease, and Survival after Unrelated Donor Transplantation with Reduced-Intensity Conditioning for Hematologic Malignancies, Biology of Blood and Marrow Transplantation, vol.17, 12, 2011,pp 1869-1873
2005Filgrastim-mobilized peripheral blood progenitor cells versus bone marrow transplantation for treating leukemia: 3-year results from the EBMT randomized trial.Bradstock, Kenneth; Apperley, J.; Bacigalupo, A.; Beksac, M.; Buzyn, A.; Gluckman, E.; Gratwohl, A.; Matcham, J.; Nagler, A.; Russell, N.; Ruutu, T.; Schlegelberger, Brigitte; Schmitz, N.; Szer, J.; Western Clinical School: Westmead Millennium InstituteFilgrastim-mobilized peripheral blood progenitor cells versus bone marrow transplantation for treating leukemia: 3-year results from the EBMT randomized trial., Haematologica: the hematology journal, vol.90,(5),2005,pp 643-648